Soo Yeun Lee

Title: Innovations of Soo Yeun Lee

Introduction

Soo Yeun Lee is an accomplished inventor based in Stanford, California. She has made significant contributions to the field of biotechnology, particularly in the development of light-responsive polypeptides and their applications. With a total of three patents to her name, her work is at the forefront of optogenetics and cellular control.

Latest Patents

Soo Yeun Lee's latest patents include "Light-responsive polypeptides and methods of use thereof." This patent provides variant light-responsive polypeptides and nucleic acids that encode these polypeptides. The methods, devices, and systems described in this patent allow for the control of cell activity expressing these polypeptides. Another notable patent is "Engineered light-activated anion channel proteins and methods of use thereof." This patent encompasses compositions, devices, systems, and methods for the optogenetic modulation of action potentials in target cells. The devices include light-generating and control devices that deliver light-responsive polypeptides or nucleic acids to target cells, facilitating the manipulation of action potentials for potential therapeutic applications.

Career Highlights

Soo Yeun Lee is affiliated with Leland Stanford Junior University, where she conducts her research and development. Her innovative work has positioned her as a key figure in the advancement of optogenetic technologies, which have vast implications for treating neurological and psychiatric conditions.

Collaborations

Soo Yeun Lee collaborates with notable researchers in her field, including Karl A. Deisseroth and Charu Ramakrishnan. These collaborations enhance the scope and impact of her research, contributing to the collective knowledge in biotechnology and optogenetics.

Conclusion

Soo Yeun Lee's contributions to the field of biotechnology through her patents and research at Leland Stanford Junior University highlight her role as an influential inventor. Her work in light-responsive polypeptides and optogenetics continues to pave the way for innovative solutions in medical science.